Colchicine causes diarrhea because it interferes with the internal scaffolding of cells throughout the body, and the cells lining your gut happen to be among the most vulnerable targets. The drug works by disrupting structures called microtubules, which are involved in nearly everything a cell does, from dividing to moving materials around. Your intestinal lining replaces itself every few days, making it one of the fastest-dividing tissues you have, and colchicine effectively catches it in the crossfire. The result is not one single problem but a pile-up of related ones: structural damage to the intestinal wall, a leakier barrier, disrupted fluid absorption, and faster movement of contents through the bowel.
What Colchicine Does Inside Cells
Colchicine is an anti-inflammatory drug used for gout flares, familial Mediterranean fever (FMF), pericarditis, and increasingly for cardiovascular protection. It works mainly by blocking the assembly of microtubules, the protein tubes that act like a cell’s internal skeleton and highway system.1PubMed. Colchicine Pharmacokinetics and Mechanism of Action Microtubules help cells hold their shape, divide, migrate, and shuttle cargo from one end to another. When colchicine binds to the protein that microtubules are built from, those tubes can’t form properly. In immune cells, that means they can’t rush to the site of inflammation as efficiently, which is exactly what makes colchicine useful. But the drug doesn’t limit itself to immune cells. It enters every tissue it reaches, and any cell that depends heavily on microtubules or rapid turnover is going to feel the impact.
Why the Gut Takes the Biggest Hit
Your intestinal lining is one of the most actively renewing surfaces in the body. Cells at the base of tiny finger-like projections called villi divide constantly, push upward, and get shed at the tips within a few days. Colchicine, which you swallow as a pill, passes directly through this tissue on its way into the bloodstream, so the gut lining gets a concentrated dose before the drug even distributes elsewhere.
On top of that, the intestinal wall is equipped with efflux pumps, proteins that actively push colchicine back out of cells and into the gut lumen. Two pumps in particular handle the bulk of this work along the entire length of the small intestine.2Drug Metabolism and Disposition. Multiple Efflux Pumps Are Involved in the Transepithelial Transport of Colchicine This sounds protective, and it does limit how much colchicine gets absorbed systemically. But it also means the drug cycles back and forth across gut cells repeatedly, giving the intestinal lining prolonged, repeated exposure. Lab studies using intestinal cell models have shown that colchicine is secreted from the blood side back into the gut lumen at roughly twenty times the rate it crosses in the absorptive direction.3PubMed. Grapefruit juice and its constituents augment colchicine intestinal absorption: potential hazardous interaction and the role of p-glycoprotein The intestinal lining, in other words, is not just an innocent bystander. It is the main battleground.
Structural Damage to the Intestinal Lining
One of the clearest signs of what colchicine does to the gut comes from biopsy studies of patients on long-term therapy. In patients with familial Mediterranean fever who took colchicine continuously, researchers found that the villi of the small intestine were significantly shorter than in healthy controls, while the crypts at the base of those villi were deeper.4Springer Link. Effect of long-term colchicine therapy on jejunal mucosa The number of dividing cells per crypt was also more than double the normal rate. This pattern, short villi with hyperactive crypts, is a hallmark of mucosal injury: the lining is being damaged and trying to compensate by producing replacement cells faster.
Shorter villi mean less surface area for absorbing nutrients and water. The gut compensates by ramping up cell production, but those new cells may not mature fully before they’re pushed into service. The net effect is an intestinal lining that is structurally compromised, less efficient at absorption, and constantly playing catch-up. That alone would tend to produce looser stools. But it’s only one piece of the puzzle.
A Leakier Intestinal Barrier
The cells of your intestinal lining are stitched together by tight junctions, protein complexes that control what passes between cells. These junctions rely on the cytoskeleton, including microtubules, to stay properly assembled. Lab studies have shown that colchicine at relevant concentrations causes marked disruption of microtubules in intestinal cell layers.5PubMed. Cytoskeletal regulation of Caco-2 intestinal monolayer paracellular permeability When those structural supports collapse, the junctions between cells loosen, and the barrier becomes more permeable.
This has been confirmed in living animals and in human patients. Rats given colchicine showed a significant increase in intestinal permeability within two days, and the effect persisted throughout the treatment period.6PubMed. Colchicine induces enhanced intestinal permeability in the rat In people with FMF taking colchicine, permeability measured by a standard sugar absorption test was roughly double that of untreated FMF patients and more than triple that of healthy controls.7PubMed. Colchicine enhances intestinal permeability in patients with familial Mediterranean fever Mouse studies have added detail, showing that colchicine reduces the levels of specific tight junction proteins in both the small intestine and the colon, while markers of barrier breakdown rise in the blood.8PubMed. Colchicine increases intestinal permeability, suppresses inflammatory responses, and alters gut microbiota in mice
A leaky gut barrier lets water and solutes pass where they shouldn’t. It can also allow bacterial components to cross into the bloodstream, potentially adding a layer of low-grade immune activation that further disturbs gut function. Together with the villous damage described above, this barrier breakdown means the intestine can neither absorb properly nor keep its contents contained.
Disrupted Fluid Absorption
Beyond structural damage, colchicine directly impairs the gut’s ability to move water in the right direction. In rat studies, colchicine cut net fluid transport in the intestine by roughly two-thirds compared to controls. The mechanism appears to involve the sodium-potassium pump (Na-K-ATPase), a key enzyme that drives fluid absorption. Colchicine reduced the activity of this pump by more than half.9PubMed Central. Effect of colchicine and vinblastine on rat intestinal water transport and Na-K-ATPase activity Less pump activity means less sodium absorbed, and where sodium goes, water follows. The practical result is that more water stays in the bowel lumen, producing watery stools.
Interestingly, separate experiments found that colchicine also interferes with the intestine’s secretory machinery. When the gut is stimulated to secrete fluid (as happens during infections or in response to certain toxins), microtubules play a role in that process, and colchicine can actually reduce stimulated secretion.10Gastroenterology. The role of microtubules in small intestinal electrolyte secretion This might seem contradictory, but the dominant everyday effect of colchicine is on the absorptive side. Under normal conditions, your gut absorbs far more fluid than it secretes, and it is the collapse of that absorptive capacity that overwhelms the system and produces diarrhea.
Faster Transit Through the Bowel
On top of everything happening at the cellular level, colchicine also speeds up how quickly contents move through your intestines. Animal studies have shown that colchicine significantly decreases intestinal transit time, meaning food and fluid spend less time in the gut.11PubMed. Effect of colchicine and bisacodyl on rat intestinal transit and nitric oxide synthase activity This effect is robust enough that colchicine has even been tested as a treatment for severe chronic constipation. In a controlled crossover trial, it increased the number of bowel movements and sped up colonic transit compared to both baseline and placebo.12PubMed. Treatment of chronic constipation with colchicine: randomized, double-blind, placebo-controlled, crossover trial
Faster transit compounds every other problem. If the lining is already struggling to absorb water and nutrients, giving it less time to do so makes the situation worse. The colon, which normally salvages a lot of water from what the small intestine passes along, can’t keep up if material arrives too quickly. The combination of impaired absorption and accelerated transit is essentially a recipe for watery, frequent stools.
The Dose Makes the Diarrhea
All of these mechanisms scale with dose, which is why the history of colchicine dosing for gout is essentially a story about diarrhea. The traditional regimen for an acute gout flare called for a loading dose followed by additional pills every hour until either the pain resolved or diarrhea started. The diarrhea, in effect, was treated as the signal to stop. That approach has been abandoned because it produced punishing GI side effects without any additional benefit over lower doses.13PubMed Central. Colchicine: the good, the bad, the ugly and how to minimize the risks
The landmark study that settled this question compared high-dose colchicine (a total of 4.8 mg over six hours) against low-dose colchicine (1.8 mg total, taken within one hour) and placebo for acute gout. The results were stark. In the high-dose group, about 77% of patients developed diarrhea, and roughly one in five had severe diarrhea. In the low-dose group, about 23% had diarrhea, none of it severe, and none of them vomited.14PubMed. High versus low dosing of oral colchicine for early acute gout flare Both doses were similarly effective at relieving gout pain compared to placebo. The take-home was clear: the higher dose bought no extra benefit but tripled-plus the diarrhea rate and introduced vomiting. Modern guidelines now recommend the lower-dose approach universally.
Even at low doses, though, diarrhea remains the most common side effect. For people taking colchicine daily for prevention (of gout flares, pericarditis recurrence, or cardiovascular events), mild and intermittent loose stools are common enough to be expected rather than surprising. The severity usually stays manageable, but it can still affect quality of life, particularly in the early weeks of therapy.
Drug Interactions That Amplify the Problem
Colchicine has a narrow therapeutic window, meaning the gap between an effective dose and a toxic one is small. That gap can shrink dangerously when other drugs interfere with how colchicine is processed. The efflux pumps that cycle colchicine out of gut cells and the liver enzyme that metabolizes it are the same systems that handle dozens of other commonly prescribed medications. When those systems are blocked, colchicine levels can spike.
The most dangerous documented interaction is with clarithromycin, a widely prescribed antibiotic that powerfully blocks both the key liver enzyme and the main efflux pump. When the two drugs are taken together, colchicine’s half-life increases dramatically, and adverse reactions including severe diarrhea, bone marrow suppression, and organ failure have been reported. In a large database of adverse event reports, diarrhea appeared in about 31% of cases involving this combination.15PubMed Central. Evidence of Clinically Meaningful Drug–Drug Interaction With Concomitant Use of Colchicine and Clarithromycin Other drugs that inhibit the same pathways, including certain antifungals, HIV protease inhibitors, and calcium channel blockers, can cause similar problems.
Even grapefruit juice inhibits the efflux pump in gut cells enough to meaningfully increase colchicine absorption. Lab studies showed that grapefruit juice boosted the amount of colchicine crossing the intestinal barrier in a concentration-dependent way by blocking efflux transport.3PubMed. Grapefruit juice and its constituents augment colchicine intestinal absorption: potential hazardous interaction and the role of p-glycoprotein More colchicine getting absorbed might sound like it would spare the gut, but higher systemic levels increase the drug’s effects on the gut from the bloodstream side too, and raise the overall risk of toxicity. The practical advice is straightforward: if you’re on colchicine, your prescriber needs a complete list of your other medications, and you should ask about grapefruit.
When Diarrhea Becomes a Red Flag
For most people on standard doses, colchicine-related diarrhea is annoying but not dangerous. It becomes a warning sign when it’s severe, persistent, or accompanied by other symptoms like vomiting, abdominal pain, or fever. In colchicine overdose or toxic accumulation, diarrhea is typically the earliest symptom, appearing within the first 10 to 24 hours as part of the first phase of toxicity. That first phase also includes volume depletion and low blood pressure from the fluid losses caused by vomiting and diarrhea.16PubMed Central. Clinical outcomes after colchicine overdose: A case report
The danger is that the GI symptoms in the first phase can look like ordinary side effects or food poisoning, and the more serious damage, including bone marrow failure, kidney injury, and cardiovascular collapse, doesn’t show up until the second phase, typically two to seven days later. There is no specific antidote for colchicine poisoning, so early recognition matters enormously.17PubMed Central. A Case of Colchicine Overdose and Toxicity If you’re taking colchicine and develop sudden, profuse diarrhea along with severe abdominal pain or repeated vomiting, that warrants urgent medical attention rather than a wait-and-see approach.
Does Colchicine Change the Gut Microbiome?
Given how much colchicine disrupts the intestinal environment, you might expect it to substantially reshape the community of bacteria living in the gut. Mouse studies have suggested it can alter microbiota composition at higher doses.8PubMed. Colchicine increases intestinal permeability, suppresses inflammatory responses, and alters gut microbiota in mice But a study in adults with metabolic syndrome who took colchicine found no significant changes in overall microbiome diversity or in the abundance of major bacterial groups. Only a single bacterial genus showed even a nominally significant change.18PubMed Central. Colchicine effects on the gut microbiome in adults with metabolic syndrome The drug clearly reduced systemic inflammation in those participants, but that anti-inflammatory benefit didn’t appear to be driven by microbiome shifts. So while the question is still open, the current human evidence suggests that colchicine’s GI side effects are mainly about direct tissue-level damage rather than a wholesale rearrangement of gut bacteria.
Living With the Side Effects
If your doctor has started you on colchicine and you’re dealing with loose stools, the first thing to know is that this is the single most common side effect and you’re far from alone. A few strategies can help. Taking colchicine with food may slow absorption somewhat and reduce the initial hit to your stomach and upper gut. Staying well hydrated matters, especially in the early days of treatment, because the fluid losses from diarrhea can compound quickly if you’re not replacing them. If diarrhea persists beyond the first couple of weeks or is disrupting your daily life, a dose adjustment is often the most effective fix, since the side effect is so tightly linked to dose.
For gout flares specifically, colchicine is just one of three first-line options. Anti-inflammatory painkillers and corticosteroids are equally accepted starting points, and newer agents targeting specific inflammatory pathways are in active development for cases where standard treatments aren’t tolerated.19Current Treatment Options in Rheumatology. A Review of Gout Flare Management Switching classes entirely may be preferable to enduring chronic GI distress, especially for people who need long-term prophylaxis.
For conditions where colchicine has a more unique role, such as familial Mediterranean fever or recurrent pericarditis, the calculus is different. The benefits of staying on the drug are often substantial and hard to replicate with alternatives. In those situations, the goal is usually to find the lowest effective dose rather than to stop the drug entirely. Splitting the daily dose across meals, avoiding known drug interactions, and being cautious with alcohol (which independently irritates the gut lining) can all help keep the side effects tolerable. Some patients find that GI symptoms improve after the first few weeks as the body adapts, though this isn’t universal.
Why Some People Are Hit Harder Than Others
Not everyone who takes colchicine gets diarrhea, and among those who do, the severity varies widely. Part of this comes down to the efflux pumps discussed earlier. The genes encoding these transporters vary between individuals. Someone with a less active version of the pump may end up with higher colchicine levels in their gut tissue and bloodstream from the same oral dose, making them more susceptible to GI effects. Similarly, people with reduced activity of the liver enzyme that breaks down colchicine will clear the drug more slowly, extending its exposure time in the gut.
Kidney and liver function also matter. Colchicine is eliminated through both pathways, and impairment in either one raises drug levels. Older adults, who often have some degree of reduced kidney function, are at higher risk for toxicity at standard doses. Pre-existing GI conditions like inflammatory bowel disease, celiac disease, or chronic diarrhea from other causes can make the intestinal lining more vulnerable to the additional insult colchicine delivers. If you already have a compromised gut barrier, the further permeability increase caused by the drug is likely to produce more noticeable symptoms.
Body weight, hydration status, and even diet composition can influence how colchicine behaves in the gut. None of these factors have been studied in enough detail to produce personalized dosing algorithms yet, so clinical practice still relies mainly on starting at a low dose, watching for GI symptoms, and adjusting from there. The relationship between colchicine and your gut is, at its core, a collision between a useful anti-inflammatory and one of the body’s most sensitive tissues, and how much collateral damage results depends on the specific biology you bring to the encounter.